PRKAA1 and metabolic dysfunction-associated steatohepatitis: The beneficial effect of activated AMPK signaling for anti-NAFLD/NASH can be achieved by regulating the metabolic homeostasis of fatty acids, alleviating oxidative stress and inflammatory response, ameliorating fibrosis, and improving liver injury.